Literature DB >> 25211750

Illness absences among beryllium sensitized workers.

Janice P Watkins1, Elizabeth D Ellis, David J Girardi, Donna L Cragle, Bonnie S Richter.   

Abstract

OBJECTIVES: This study examined absence rates among US Department of Energy workers who had beryllium sensitization (BeS) or were diagnosed with chronic beryllium disease (CBD) compared with those of other workers.
METHODS: We used the lymphocyte proliferation test to determine beryllium sensitivity. In addition, we applied multivariable logistic regression to compare absences from 2002 to 2011 between workers with BeS or CBD to those without, and survival analysis to compare time to first absence by beryllium sensitization status. Finally, we examined beryllium status by occupational group. Results. Fewer than 3% of the 19,305 workers were BeS, and workers with BeS or CBD had more total absences (odds ratio [OR] = 1.31; 95% confidence interval [CI] = 1.18, 1.46) and respiratory absences (OR = 1.51; 95% CI = 1.24, 1.84) than did other workers. Time to first absence for all causes and for respiratory conditions occurred earlier for workers with BeS or CBD than for other workers. Line operators and crafts personnel were at increased risk for BeS or CBD. Conclusions. Although not considered "diseased," workers with BeS have higher absenteeism compared with nonsensitized workers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25211750      PMCID: PMC4202958          DOI: 10.2105/AJPH.2014.302132

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

1.  Chronic beryllium disease prevention program. Office of Environment, Safety and Health, Department of Energy. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1999-12-08

2.  Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.

Authors:  Laura Welch; Knut Ringen; Eula Bingham; John Dement; Tim Takaro; William McGowan; Anna Chen; Patricia Quinn
Journal:  Am J Ind Med       Date:  2004-09       Impact factor: 2.214

3.  Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.

Authors:  Christine R Schuler; Michael S Kent; David C Deubner; Michael T Berakis; Michael McCawley; Paul K Henneberger; Milton D Rossman; Kathleen Kreiss
Journal:  Am J Ind Med       Date:  2005-03       Impact factor: 2.214

4.  Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.

Authors:  Marek A Mikulski; Stephanie A Leonard; Wayne T Sanderson; Patrick G Hartley; Nancy L Sprince; Laurence J Fuortes
Journal:  Am J Ind Med       Date:  2010-10-28       Impact factor: 2.214

5.  Beryllium particulate exposure and disease relations in a beryllium machining plant.

Authors:  P C Kelleher; J W Martyny; M M Mroz; L A Maier; A J Ruttenber; D A Young; L S Newman
Journal:  J Occup Environ Med       Date:  2001-03       Impact factor: 2.162

6.  Beryllium sensitization and lung function among former workers at the Nevada Test Site.

Authors:  Ema G Rodrigues; Michael D McClean; Janice Weinberg; Lewis D Pepper
Journal:  Am J Ind Med       Date:  2008-07       Impact factor: 2.214

7.  Epidemiology of beryllium sensitization and disease in nuclear workers.

Authors:  K Kreiss; M M Mroz; B Zhen; J W Martyny; L S Newman
Journal:  Am Rev Respir Dis       Date:  1993-10

8.  Early pulmonary physiologic abnormalities in beryllium disease.

Authors:  G P Pappas; L S Newman
Journal:  Am Rev Respir Dis       Date:  1993-09

9.  Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.

Authors:  Lee S Newman; Margaret M Mroz; Ronald Balkissoon; Lisa A Maier
Journal:  Am J Respir Crit Care Med       Date:  2004-09-16       Impact factor: 21.405

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.